DocDollars

Grifols Therapeutics LLC

CA · United States · Reporting entity ID 100000005422

Total reported 2019–2025
$16.1M
#370 of 2,960 reporting companies — 0% of all reported industry payments
$28K in general payments across 61 records, plus $16.0M in research funding across 1,679 records.

How it breaks down

General payments $27,907
Research funding $16,025,727

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Grifols Therapeutics LLC reported $16.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #370 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 61 general payment records and 1,679 research records were filed.

Common questions about Grifols Therapeutics LLC

How much has Grifols Therapeutics LLC paid US doctors?

Grifols Therapeutics LLC reported $16,053,634 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $27,907 in general payments, $16,025,727 in research funding.

How does Grifols Therapeutics LLC rank among drug and device companies?

It ranks #370 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Grifols Therapeutics LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.